The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate
Ann Oncol
.
2021 May;32(5):579-581.
doi: 10.1016/j.annonc.2021.01.068.
Epub 2021 Feb 12.
Authors
M C Garassino
1
,
M Vyas
2
,
E G E de Vries
3
,
R Kanesvaran
4
,
R Giuliani
5
,
S Peters
6
;
European Society for Medical Oncology
Affiliations
1
Thoracic Oncology, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address:
[email protected]
.
2
European Society for Medical Oncology, Lugano, Switzerland.
3
Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands.
4
Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
5
The Clatterbridge Cancer Centre, Liverpool, UK.
6
Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
PMID:
33582237
PMCID:
PMC7879154
DOI:
10.1016/j.annonc.2021.01.068
No abstract available
Publication types
Editorial
MeSH terms
COVID-19 Vaccines
COVID-19*
Humans
Neoplasms* / therapy
SARS-CoV-2
Vaccination
Substances
COVID-19 Vaccines